My watch list  

Thomas Meier to become new COO of Bachem Group


Bachem announced that Thomas Meier will succeed Dr. Alex Fässler as Chief Operations Officer of Bachem Group with effect from January 1, 2019. Dr. Alex Fässler will retire at the end of April 2019 yet will continue to serve the company in an advisory capacity.

Thomas Meier was born in 1968 in Schaffhausen. After an apprenticeship as chemical laboratory technician at the ETH in Zurich, Thomas Meier obtained a degree in chemistry from the ZHAW School of Engineering. He joined Bachem AG in 1993 as Team Head, Active Pharmaceutical Ingredients. From 2001 to 2004, he headed up peptide manufacturing at Peninsula Laboratories, Inc. in San Carlos, California. On his return to Switzerland, he was in charge of solid-phase peptide manufacturing for Bachem AG in Bubendorf. He assumed overall responsibility for production at the Bubendorf site in 2013, and was appointed COO Europe in August 2017, with responsibility for all production sites in Switzerland, Germany, and the UK. Parallel to working, Thomas Meier obtained a degree as Industrial Engineer STA (Swiss Technical Association) and completed the Advanced Management Programme at INSEAD Business School, Fontainebleau/Paris.

Dr. Kuno Sommer, Chairman of Bachem's Board of Directors, remarked: “We are delighted to have found a very experienced and competent internal successor for Alex Fässler in the person of Thomas Meier. Thanks to his many years of service with Bachem, he will ensure continuity in this key function, is already well acquainted with the demanding tasks involved, and has an excellent network both inside the Group and beyond. We wish to thank Alex Fässler for the substantial contribution he has made to shaping Bachem’s success story over 20 years and in various positions. He is handing over to his successor an organization with global capabilities and state-of-the-art production facilities. We wish him all the best for the future and wish Thomas Meier every success in his role as Bachem's Chief Operations Officer.”

Facts, background information, dossiers
  • Bachem
  • appointments
More about Bachem
  • News

    Bachem to expand in asian markets

    Bachem announces the establishment of Bachem Japan K.K., a subsidiary in Tokyo, Japan. This new local presence in Asia will strengthen project and customer support and drive further business growth in the Asian market."This is an exciting step for Bachem", comments Dr. Anne-Kathrin Stoller, ... more

    Bachem expands its Corporate Executive Committee

    Bachem announced that Dr. Alex Fässler has been appointed to its Corporate Executive Committee as a new member, effective April 1, 2017. Alex Fässler will have global responsibility for the Group’s production sites as Chief Operations Officer (COO). He will strengthen the Corporate Executiv ... more

    Bachem renews supply contract with AstraZeneca

    The Bachem Group announced the renewal of its supply agreement with AstraZeneca for the peptide active substance Goserelin. The extended partnership enhances the cooperation between both companies. Under the terms of the agreement, AstraZeneca will continue acquiring the peptide active subs ... more

  • Videos

    Corporate Video Bachem AG


  • Companies

    Bachem Distribution Services GmbH

    Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry. Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as ... more

    Bachem AG

    Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based acti ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE